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MONOZYGOTIC TWINS DISCORDANT FOR
NARCOLEPSY TYPE 1 AND MULTIPLE
SCLEROSIS
Narcolepsy type 1 (NC1) is a neurologic sleep disorder
caused by the loss of hypothalamic neurons that produce
the sleep–wake regulating neuropeptides, the hypocretins
(orexins). The pathogenesis is believed to be mainly
autoimmune, based on the observation of a 95% to
100% association with the HLA-DQB1*06:02 allele,
and on the recent strong indication of antigen presenta-
tion to T cells as central factors.1 In Caucasians and
Asians, the DQB1*06:02 allele is tightly linked to the
HLA-DRB1*15:01 allele, which itself is associated with
multiple sclerosis (MS), a CNS autoimmune disorder.
Herein, we describe a DRB1*15:01/DQB1*06:02-
positive monozygotic twin pair discordant for NC1
and MS.
Case report. In 2004, a 34-year-old, otherwise healthy
Caucasian man (twin A) was diagnosed with narcolepsy
NC1, 19 years after the onset of sleepiness. At the time
of diagnosis, he presented severe daytime sleepiness
(Epworth Sleepiness Scale score of 22/24), hypnagogic
hallucinations, and dream enactment during sleep
(REM sleep behavior disorder), but no cataplexy
or sleep paralyses. Sleep investigations confirmed
narcolepsy: the polysomnography was normal except
for REM sleep without atonia, which was consistent
with the reported dream enactment; the Multiple
Sleep Latency Test showed a mean sleep latency of
6 minutes, with sleep-onset REM periods in 4 of 4
naps. He was hypocretin-deficient (CSF hypocretin-1:
58 pg/mL, compared with normal levels of $200
pg/mL) and his HLA type was DRB1*15:01/13:01;
DQB1*06:02/06:03. In 2008, cataplexy triggered by
laughter and surprise evolved. In 2011, serologic tests
confirmed Epstein-Barr/cytomegaloviral infection and
he experienced temporary leg paraesthesia, from which
he quickly and fully recovered. Neurologic examinations,
MRI of the brain and spinal cord, and measurement of
the immunoglobulin G (IgG) index gave normal results.
Oligoclonal bands were absent. The low CSF
hypocretin-1 level was unchanged.
In 2006, his brother (twin B) was healthy, with
a normal Epworth Sleepiness Scale score (8/24) and
no narcoleptic symptoms. He declined to participate
in sleep investigations, but was confirmed to be
DRB1*15:01/13:01; DQB1*06:02/06:03-positive.
In 2010, he developed bilateral hand/forearm paraes-
thesia. MRI of the brain and neck revealed.9 demy-
elinating periventricular lesions and a hyperintense
lesion at the C2 level. Definite MS was diagnosed
according to the 2010 revised McDonald criteria2
after an additional clinical attack, an elevated IgG
index (1.22), and the presence of oligoclonal bands
in the CSF. The CSF hypocretin-1 level was normal
(283 pg/mL). He confirmed that he experienced
“tiredness” (fatigue), but reported no sleep attacks
or other core narcoleptic symptoms. As narcolepsy
was not suspected and because he had a severe crisis
reaction after his MS diagnosis, we refrained from
undertaking a sleep investigation.
TheDNAwas typed for monozygosity using 16 poly-
morphic microsatellite (short tandem repeat) markers:
D1S1656, D2S441, D2S1338, D3S1358, D8S1179,
D10S1248, D12S391, D16S539, D18S51, D19S433,
D21S11, D22S1045, FGA, SE33, TH01, vWA, and
the sex marker Amelogenin (AmpFLSTR NGM Select
PCR Amplification kit; ThermoFisher Scientific, Wal-
tham, MA). The likelihood ratio in favor of monozygos-
ity was greater than 10,000:1.
Discussion. The present case is notable for several
reasons. Monozygotic twin pairs discordant for NC1
and MS are rare. The presence of MS—an autoim-
mune CNS disorder—in the genetically identical twin
of a hypocretin-deficient patient with narcoleptic
supports the pathophysiologic importance of the
recently found association between NC1 and genes
involved in antigen processing, presentation, and
T cell response.1
Comorbid autoimmune disease3 and cases of co-
morbid MS have been observed in single cases of
sporadic NC1 and, notably, in an H1N1-vaccinated
NC1 patient.4 We have previously reported that
sleepiness and hypocretin levels are generally normal
in MS,5 but secondary hypocretin deficiency and hy-
persomnia/NC1 have been reported in a few cases of
neuromyelitis optica.6 The NC1- and MS-
predisposing HLA-DRB1*15:01/DQB1*06:02 hap-
lotype is also found in approximately 25% of the
general population. Several other predisposing genes,
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none of which overlap, have been reported and account
for some of the missing heritability in both diseases.
However, the present monozygotic twin A, who, when
last examined, still had isolated NC1 without signs of
comorbid MS, and twin B, who still had isolated MS
without signs of secondary NC1, had an asymptomatic
DRB1*15:01/DQB1*06:02 homozygote father and
an asymptomatic DRB1*15:01/DQB1*06:02-negative
mother. This strongly suggests that a shared genetic
background of DRB1*15:01/DQB1*06:02 is not suf-
ficient to account for a predisposition to either of these
autoimmune CNS disorders. Additional predisposing
genes are most likely uncommon since comorbidity is
rare, but environmental factors, for example, bacterial or
viral infections, are believed to be equally important in
the pathogenesis of autoimmune disorders. Pandemrix
is a vaccine whose effect is reduced in patients with MS
treated with immunomodulatory drugs such as glatir-
amer acetate or natalizumab but not in patients on
interferon b.7 Given the dramatic increase of NC1 cases
following H1N1 vaccinations with Pandemrix (GlaxoS-
mithKline), our present twin case and cases of comorbid
MS and NC1 after H1N1 vaccination4 could be valu-
able for further studies of the genetic background and
specific triggers (or drivers) of autoimmunity in these
CNS disorders.
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